Nuevo uso de formulación inmunogénica bcg que expresa una proteína de virus respiratorio sincicial contra hmpv
La invención se refiere al nuevo uso de una formulación inmunogénica que contiene la cepa Bacilo de Calmette y Guerin (BCG) en una concentración entre 104-109 bacterias, que expresa al menos una proteína o fragmento inmunogénico del virus respiratorio sincicial (VRS, Human orthopneumovirus), en una...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PABLO ALBERTO GONZÁLEZ MUÑOZ SUSAN MARCELA BUENO RAMÍREZ ALEXIS MIKES KALERGIS PARRA |
| description | La invención se refiere al nuevo uso de una formulación inmunogénica que contiene la cepa Bacilo de Calmette y Guerin (BCG) en una concentración entre 104-109 bacterias, que expresa al menos una proteína o fragmento inmunogénico del virus respiratorio sincicial (VRS, Human orthopneumovirus), en una solución tampón salina farmacéuticamente aceptable porque sirve para preparar una vacuna útil para prevenir prevenir, tratar, o atenuar infecciones de metapneumovirus humano (hMPV).
The invention relates to the novel use of an immunogenic formulation containing the bacillus Calmette-Guérin (BCG) strain at a concentration between 104-109 bacteria, expressing at least one protein or immunogenic fragment of respiratory syncytial virus (RSV, Human orthopneumovirus), in a pharmaceutically acceptable saline buffer solution because it serves to prepare a vaccine useful to prevent, treat, or attenuate human metapneumovirus (hMPV) infections. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2019003847A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2019003847A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2019003847A13</originalsourceid><addsrcrecordid>eNqNizsKwlAQRdNYiLqHAWshUUEtJSgWYmUfxuckDiQzL-8T3JKFlUvIxkzhAqzOhXPPOGkvkTqF6BXuBKW6JtZouP8IsDRRtOpfwgbhZipoIwE9rSOPEAXBOg3Uv4c1tB276GFwlh0GdazgWQwbxhqMSnAIj8Z202RUYu1p9uMkmR8P1_y0IKvFUKMhoVDk52Wa7dJ0tV1v9tnqv9cXOH5HBw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Nuevo uso de formulación inmunogénica bcg que expresa una proteína de virus respiratorio sincicial contra hmpv</title><source>esp@cenet</source><creator>PABLO ALBERTO GONZÁLEZ MUÑOZ ; SUSAN MARCELA BUENO RAMÍREZ ; ALEXIS MIKES KALERGIS PARRA</creator><creatorcontrib>PABLO ALBERTO GONZÁLEZ MUÑOZ ; SUSAN MARCELA BUENO RAMÍREZ ; ALEXIS MIKES KALERGIS PARRA</creatorcontrib><description>La invención se refiere al nuevo uso de una formulación inmunogénica que contiene la cepa Bacilo de Calmette y Guerin (BCG) en una concentración entre 104-109 bacterias, que expresa al menos una proteína o fragmento inmunogénico del virus respiratorio sincicial (VRS, Human orthopneumovirus), en una solución tampón salina farmacéuticamente aceptable porque sirve para preparar una vacuna útil para prevenir prevenir, tratar, o atenuar infecciones de metapneumovirus humano (hMPV).
The invention relates to the novel use of an immunogenic formulation containing the bacillus Calmette-Guérin (BCG) strain at a concentration between 104-109 bacteria, expressing at least one protein or immunogenic fragment of respiratory syncytial virus (RSV, Human orthopneumovirus), in a pharmaceutically acceptable saline buffer solution because it serves to prepare a vaccine useful to prevent, treat, or attenuate human metapneumovirus (hMPV) infections.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210806&DB=EPODOC&CC=CL&NR=2019003847A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210806&DB=EPODOC&CC=CL&NR=2019003847A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PABLO ALBERTO GONZÁLEZ MUÑOZ</creatorcontrib><creatorcontrib>SUSAN MARCELA BUENO RAMÍREZ</creatorcontrib><creatorcontrib>ALEXIS MIKES KALERGIS PARRA</creatorcontrib><title>Nuevo uso de formulación inmunogénica bcg que expresa una proteína de virus respiratorio sincicial contra hmpv</title><description>La invención se refiere al nuevo uso de una formulación inmunogénica que contiene la cepa Bacilo de Calmette y Guerin (BCG) en una concentración entre 104-109 bacterias, que expresa al menos una proteína o fragmento inmunogénico del virus respiratorio sincicial (VRS, Human orthopneumovirus), en una solución tampón salina farmacéuticamente aceptable porque sirve para preparar una vacuna útil para prevenir prevenir, tratar, o atenuar infecciones de metapneumovirus humano (hMPV).
The invention relates to the novel use of an immunogenic formulation containing the bacillus Calmette-Guérin (BCG) strain at a concentration between 104-109 bacteria, expressing at least one protein or immunogenic fragment of respiratory syncytial virus (RSV, Human orthopneumovirus), in a pharmaceutically acceptable saline buffer solution because it serves to prepare a vaccine useful to prevent, treat, or attenuate human metapneumovirus (hMPV) infections.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizsKwlAQRdNYiLqHAWshUUEtJSgWYmUfxuckDiQzL-8T3JKFlUvIxkzhAqzOhXPPOGkvkTqF6BXuBKW6JtZouP8IsDRRtOpfwgbhZipoIwE9rSOPEAXBOg3Uv4c1tB276GFwlh0GdazgWQwbxhqMSnAIj8Z202RUYu1p9uMkmR8P1_y0IKvFUKMhoVDk52Wa7dJ0tV1v9tnqv9cXOH5HBw</recordid><startdate>20210806</startdate><enddate>20210806</enddate><creator>PABLO ALBERTO GONZÁLEZ MUÑOZ</creator><creator>SUSAN MARCELA BUENO RAMÍREZ</creator><creator>ALEXIS MIKES KALERGIS PARRA</creator><scope>EVB</scope></search><sort><creationdate>20210806</creationdate><title>Nuevo uso de formulación inmunogénica bcg que expresa una proteína de virus respiratorio sincicial contra hmpv</title><author>PABLO ALBERTO GONZÁLEZ MUÑOZ ; SUSAN MARCELA BUENO RAMÍREZ ; ALEXIS MIKES KALERGIS PARRA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2019003847A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PABLO ALBERTO GONZÁLEZ MUÑOZ</creatorcontrib><creatorcontrib>SUSAN MARCELA BUENO RAMÍREZ</creatorcontrib><creatorcontrib>ALEXIS MIKES KALERGIS PARRA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PABLO ALBERTO GONZÁLEZ MUÑOZ</au><au>SUSAN MARCELA BUENO RAMÍREZ</au><au>ALEXIS MIKES KALERGIS PARRA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Nuevo uso de formulación inmunogénica bcg que expresa una proteína de virus respiratorio sincicial contra hmpv</title><date>2021-08-06</date><risdate>2021</risdate><abstract>La invención se refiere al nuevo uso de una formulación inmunogénica que contiene la cepa Bacilo de Calmette y Guerin (BCG) en una concentración entre 104-109 bacterias, que expresa al menos una proteína o fragmento inmunogénico del virus respiratorio sincicial (VRS, Human orthopneumovirus), en una solución tampón salina farmacéuticamente aceptable porque sirve para preparar una vacuna útil para prevenir prevenir, tratar, o atenuar infecciones de metapneumovirus humano (hMPV).
The invention relates to the novel use of an immunogenic formulation containing the bacillus Calmette-Guérin (BCG) strain at a concentration between 104-109 bacteria, expressing at least one protein or immunogenic fragment of respiratory syncytial virus (RSV, Human orthopneumovirus), in a pharmaceutically acceptable saline buffer solution because it serves to prepare a vaccine useful to prevent, treat, or attenuate human metapneumovirus (hMPV) infections.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_CL2019003847A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Nuevo uso de formulación inmunogénica bcg que expresa una proteína de virus respiratorio sincicial contra hmpv |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A18%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PABLO%20ALBERTO%20GONZ%C3%81LEZ%20MU%C3%91OZ&rft.date=2021-08-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2019003847A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |